November 2025

38 Articles

No Section

Differences in indications, contraindications, and prescribing patterns for heart failure between specialties: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry

27 August 2025
Author(s): Jason A Gencher, Samaneh Salimian, Ricky D Turgeon, Penny Tam, Nathaniel M Hawkins, VOCAL-AHF study group

Heart failure (HF) is a major public health challenge affecting over 64 million adults worldwide and a leading cause of hospitalization [1]. Despite therapeutic advances, the prognosis remains poor,... more

Clinical Insights

New perspectives on heart-brain interactions: Is it time to classify cardio-neurological syndromes?

23 August 2025
Author(s): Camilla Grifoni, Paolo Fucini, Iacopo Olivotto

The interplay between heart and brain is bi-directional, complex and profound. Each system influences the other in health as well as in disease, when dysfunction in one organ has broad and as yet... more

Commentary

Post-extubation high-flow nasal cannula (HFNC) therapy with a ROX index-based strategy: A real step forward in weaning?

8 September 2025
Author(s): Lara Pisani, Roberto Dongilli

Extubation, along with the entire process of weaning from invasive mechanical ventilation (IMV), represents a key phase in the management of the critically ill patient, as it significantly impacts... more

Navigating the pitfalls of pulmonary function testing in chronic lung allograft dysfunction and chronic pulmonary graft-versus-host disease

4 September 2025
Author(s): Libor Fila, Andrea Zajacova

Chronic lung allograft dysfunction (CLAD) and pulmonary chronic graft-versus-host disease (Pc-GVHD) represent the major late non-infectious pulmonary complications following lung and allogeneic... more

Molecular echoes of CPAP: Tracking hypoxia-sensitive non-coding RNAs in obstructive sleep apnea

27 August 2025
Author(s): María C García-Hidalgo, David de Gonzalo-Calvo

Obstructive sleep apnea (OSA) is a common and increasingly recognized disorder with complex systemic implications [1]. Beyond intermittent hypoxia and sleep fragmentation, OSA has been linked to... more

Standard acute myocardial infarction without standard modifiable risk factors

16 August 2025
Author(s): Stefano Savonitto, Simona Giampaoli, Giuseppe De Luca

The identification of risk factors for cardiovascular diseases (CVD) using longitudinal cohort studies has been a major advance in medicine during the second half of the past century and, stimulating... more

Editorial

Point-of-care ultrasonography (POCUS): a substantial help for the internists with some caveats

6 October 2025
Author(s): Giancarlo Agnelli

Prior to the introduction of the point-of-care-ultrasonography (POCUS) in clinical practice, internists relied on the stethoscope and physical examination to guide patient management. Largely used by... more

Internal Medicine Flashcard

A man with fever, retinal artery occlusion, atrioventricular block and bilateral renal masses

7 August 2025
Author(s): Raül Jordà-Sánchez, Rafael Salvador, Sergio Prieto-González

A 61-year-old man with a history of recurrent otitis and recent evaluation for submandibular salivary gland enlargement presented with sudden vision loss in the left eye. He also reported fever and... more

Progressive nodules in bilateral lower extremities

29 July 2025
Author(s): Wanting Yu, Hong Shen, Zehu Liu

A 58-year-old female patient presented with asymptomatic nodules that had been on her lower legs for 10 years. The nodules appeared spontaneously without any discernible cause and progressively... more

Recurrent bilateral infrapatellar subcutaneous nodules: what is the diagnosis?

28 July 2025
Author(s): Rodrigo Villaseñor-Echavarri, Yann Charli-Joseph, Gabriela Sánchez-Cárdenas

A 32-year-old Hispanic man presented with a one-month history of bilateral infrapatellar tender erythematous subcutaneous nodules (Fig. 1, a and b), accompanied by dysesthesias in the same area and... more

Letter to the Editor

Annual chest computed tomography in multimorbid COPD: is universal screening clinically feasible?

30 September 2025
Author(s): Shilun Yu, Jinliang Han, Luyu Yue, Yunlong Song

Dear Editor,

Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus. Author’s Reply

22 September 2025
Author(s): Rossella Cannarella, Michele Rubulotta, Vittorio Cannarella, Sandro La Vignera, Aldo E. Calogero

We appreciate the authors’ thoughtful letter and their emphasis on the growing body of evidence linking sodium-glucose cotransporter 2 inhibitors (SGLT2is) treatment to enhanced erythropoiesis and... more

Annual chest computed tomography in multimorbid COPD: Is universal screening clinically feasible? Author's reply

15 September 2025
Author(s): Bartolome R. Celli, Leonardo M. Fabbri, all co-authors

Dear Editor,

Not all immunosuppression is equal: Implications for post-discharge outcomes in community-acquired pneumonia

8 September 2025
Author(s): Guangdong Wang, Tingting Liu, Wenwen Ji, Zhihong Shi

We appreciate the authors’ important contribution on post-discharge outcomes in community-acquired pneumonia (CAP)[1]. One key concern lies in the treatment of “immunosuppression” as a unitary... more

Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus

6 September 2025
Author(s): Philip Murphy

In their recent review, Cannarella et al. describe a number of advantages of sodium-glucose cotransporter 2 inhibitors (SGLT2is) beyond simple glycemic control, including important cardio-renal... more

Cardiac outcomes in hypertrophic cardiomyopathy treated with beta-blockers or verapamil

5 August 2025
Author(s): Laurent Fauchier, Lisa Lochon, Thibault Lenormand, Alexandre Bodin, Arnaud Bisson

In hypertrophic cardiomyopathy (HCM), beta-blockers (BBs) and non-dihydropyridine calcium channel blockers (particularly verapamil) are both used to manage symptoms such as dyspnea, chest pain, and... more

Effect of resmetirom on lipid profile and adiponectin levels

5 August 2025
Author(s): Luis E. Simental-Mendía, Mario Simental-Mendía, Laura Jazel Barragán-Zúñiga, Litzy Navarro-Tinoco

Resmetirom, a novel liver-targeted selective thyroid hormone receptor-beta (THR-β) agonist, has shown positive effects for the treatment of dyslipidemia and other metabolic disorders, including non-... more

Mapping the clinical trial landscape of gut microbiota modulation in neurodegenerative diseases

3 July 2025
Author(s): Hui Chen

Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS), are increasingly recognized as major contributors to the global burden of disease... more

Association of serum potassium time in target range with all-cause and cardiovascular mortality in HFrEF patients

3 July 2025
Author(s): Wenlong Xu, Yifei Ruan, Zhiwen Xiao, Xiaobo Huang, Yanmei Chen

Dyskalemia is relatively common in heart failure with reduced ejection fraction (HFrEF). Both hypokalemia and hyperkalemia exhibit U-shaped associations with adverse outcomes in HFrEF, including... more

Extended anticoagulation therapy on clinical outcomes in patients with gastrointestinal cancer and isolated distal deep vein thrombosis: Insights from the ONCO DVT Study

30 June 2025
Author(s): Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Koh Ono, Takeshi Kimura, ONCO DVT Study Investigators

The current guidelines have recommended prolonged anticoagulation therapy with direct oral anticoagulants (DOACs) as a potential treatment option for patients with cancer-associated venous... more

Cancer treatment-associated hypomagnesemia: Analysis from a large pharmacovigilance database

30 June 2025
Author(s): Nattawat Klomjit, Richard Evans, Meghan E. Sise, Kenar D. Jhaveri, Shruti Gupta, on behalf of the Hypomagnesemia in Cancer Treatment Working Group

Hypomagnesemia is common among patients with cancer, and can lead to increased morbidity and mortality as well as discontinuation of potentially life-saving treatments. Hypomagnesemia may occur due... more

Original Article

Cluster analysis for clinical, radiological, and histopathological profiling in chronic pulmonary graft-versus-host disease

28 July 2025
Author(s): Sara Piciucchi, Marco Chilosi, Giuseppe Alfano, Simone Petrarulo, Roland Barbante, Emanuela Giampalma, Claudia Ravaglia, Pier Luigi Zinzani, Venerino Poletti

Chronic pulmonary graft-versus-host disease (Pc-GVHD) is a non-infectious complication of allogeneic hematopoietic stem cell transplantation (HSCT), typically presenting >100 days post-... more

sTREM2 evaluation in women with metabolic dysfunction-associated steatotic liver disease: Advancing diagnostic approaches for early MASH

27 July 2025
Author(s): Razieh Mahmoudian, Helena Clavero-Mestres, Elena Cristina Rusu, Vicente Arredondo-Prats, Carmen Aguilar, Javier U Chicote, Salomé Martinez, David Riesco, Èlia Bartra, Anna Trinidad Borras, Fàtima Sabench, Teresa Auguet

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD) [1], is an emerging public health concern affecting approximately 32.4... more

Association between serum potassium variability during hospitalization and clinical outcomes in patients with heart failure

16 July 2025
Author(s): Yoshinori Suzuki, Tomofumi Misaka, Yu Sato, Satoshi Okochi, Ryo Ogawara, Shohei Ichimura, Tetsuro Yokokawa, Akihiko Sato, Takeshi Shimizu, Takamasa Sato, Takashi Kaneshiro, Masayoshi Oikawa, Atsushi Kobayashi, Akiomi Yoshihisa, Yasuchika Takeishi

Serum potassium levels are tightly regulated within a narrow physiological range, typically 3.5–5.0 mEq/L [1]. Potassium homeostasis involves maintaining a concentration gradient between... more

Clinical characteristics and outcomes of patients with acute myocardial Infarction without standard modifiable risk factors (SMuRFs)

12 July 2025
Author(s): Dimitrios V. Moysidis, Vasileios Anastasiou, Stylianos Daios, Andreas S. Papazoglou, Efstratios Karagiannidis, Barbara Fyntanidou, Vasileios Kamperidis, Matthaios Didagelos, Sonia Konstantinidou, Christos Savopoulos, Kali Makedou, Panagiotis Kyriakidis, George Giannakoulas, Antonios Ziakas, Georgios Giannopoulos, Vassilios Vassilikos

The etiology as well as the prevalence of acute myocardial infarction (AMI) in patients without history of standard modifiable risk factors (SMuRFs) remains unclear, especially in European... more

Deterioration of renal function is delayed in patients with atrial fibrillation treated with direct oral anticoagulants compared to vitamin K antagonists: systematic review and meta-analysis

9 July 2025
Author(s): Anastasia Adamou, Ioannis Kyriakoulis, Polyxeni Botou, Ioannis Belios, Iliana Stamatiou, David Dimitris Chlorogiannis, Theodoros Mavridis, George Ntaios

The use of anticoagulants has been linked to anticoagulant-related nephropathy (ARN), a condition initially reported in patients treated with warfarin [1]. However, cases have also been documented in... more

Point of care ultrasound (POCUS) applications in the ambulatory internal medicine setting: A scoping review

7 July 2025
Author(s): Michael Pratte, Mathilde Gaudreau-Simard, Sydney Ruller, Kordan Harvey, Valentina Ly, Jessica Evans

Point of care ultrasound (POCUS) is an increasingly recognized tool in internal medicine, with evidence supporting its use largely derived in the inpatient setting. We endeavored to provide an... more

Modulation of hypoxia-sensitive non-coding RNAs following continuous positive airway pressure therapy in obstructive sleep apnea in peripheral blood

2 July 2025
Author(s): Francesco Fanfulla, Veronica Barbi, Tiziana Bachetti, Roberto Maestri, Elena Robbi, Alessia Mongelli, Teresa Lucia Aloi, Caterina Pronzato, Michela Gottardi Zamperla, Simona Greco, Fabio Martelli, Maria Teresa La Rovere, Carlo Gaetano

Obstructive sleep apnea (OSA) is a chronic clinical condition characterized by recurrent apnea or hypopnea during sleep, leading to intermittent hypoxemia, arousal, and sleep fragmentation. OSA... more

Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study

28 June 2025
Author(s): Irene Mattioli, Michela Gasparotto, Alberto Bergamini, Alessandra Bortoluzzi, Francesco Ciccia, Fabrizio Conti, Maria Antonietta D'agostino, Micaela Fredi, Roberto Giacomelli, Florenzo Iannone, Ilaria Mormile, Matteo Piga, Luca Quartuccio, Gian Domenico Sebastiani, Chiara Tani, Angelo Vacca, Margherita Zen, Alessandra Bettiol, Giacomo Emmi, ESCULAPIO consortium

Systemic Lupus Erythematosus (SLE) is a multifaceted systemic autoimmune disorder distinguished by a diverse array of clinical manifestations that can potentially impact any organ or system in the... more

Survival effect of early high-flow nasal oxygen after the extubation of patients in the intensive care unit

24 June 2025
Author(s): Atsushi Ishihara, Hideshi Okada, Teruki Mori, Takashi Yoshizane, Kentaro Morishita, Takuji Yamamoto, Izumi Toyoda, Toshiyuki Noda

Spontaneous awakening trial (SAT) and spontaneous breathing trial (SBT) protocols for mechanically ventilated patients in the intensive care unit (ICU) have been shown to reduce the duration of... more

Review Article

T follicular helper cells (TFH): From physiological to pathological aging

6 September 2025
Author(s): Laura de Lisio, Remo Poto, Laura Andreea Ceparano, Grazia Daniela Femminella, Antonietta Liotti, Veronica De Rosa, Gilda Varricchi, Giuseppe Rengo

Human longevity has increased worldwide, partly due to medical improvements, better sanitation and easier access to clean water [1]. As the population ages, age-related diseases are leading to... more

The role of the senescence-associated secretory phenotype in cardiovascular disease among the elderly

25 August 2025
Author(s): Henry Sutanto, Deasy Fetarayani, M. Rosyid Narendra, Sally Aman Nasution

Aging is a major independent risk factor for cardiovascular disease (CVD), the leading cause of death worldwide, particularly in older adults [1,2]. With global population aging, the burden of age-... more

Management of asymptomatic patients with abnormal liver function tests

9 August 2025
Author(s): Stella Gabeta, George N. Dalekos, Nikolaos K. Gatselis

Liver function tests (LFTs) are regularly included in screening blood panels, making them among the most frequently requested laboratory tests in clinical practice [1–3]. Their widespread use and... more

Effect of sodium-glucose cotransporter-2 inhibitors on skeletal muscle

23 July 2025
Author(s): Claudia Stöllberger, Josef Finsterer, Birke Schneider

Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) are increasingly prescribed for diabetic and nondiabetic patients with and without heart failure (HF) or renal insufficiency [1]. SGLT2i reduce... more

Point of care ultrasound: focus on evidence for a critical appraisal

16 June 2025
Author(s): E. Ceriani, R. Schiavon, L. La Cava, C. Ruscitti, C. Cogliati

The term point of care ultrasound (POCUS) refers to a sonographic examination directly performed at the patient’s bedside, ideally by the treating physician, to interpret and integrate images into... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness